These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 15062159)

  • 1. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
    Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
    Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
    Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
    Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
    Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
    Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
    Stock RG; Stone NN; Lo YC
    Tech Urol; 2000 Jun; 6(2):95-8. PubMed ID: 10798807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
    Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
    Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
    Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
    Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
    Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
    Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
    Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
    Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
    Bowes D; Crook JM; Araujo C; Batchelar D
    Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
    Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
    Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
    Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.